About: Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.44 (+4.49%)
AVTX NASDAQ Avalo Therapeutics Inc
Avalo Therapeutics Inc share price
Atividade de preço de AVTX
Último preço
$ 7,440
Variação (24h)
0,32 USD (4,49%)
Volume
2.27M
Volume (média 4 sem.)
-
Abertura
$ 7,18
Variação do dia
$ 7,18 - $ 7,71
Fechamento anterior
$ 7,12
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
AVTX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals